Symlin FDA Approval History
FDA Approved: Yes (First approved March 16, 2005)
Brand name: Symlin
Generic name: pramlintide acetate
Dosage form: Injection
Company: Amylin Pharmaceuticals, Inc.
Treatment for: Diabetes, Type 1, Diabetes, Type 2
Symlin (pramlintide acetate) is an antihyperglycemic drug for use in patients with diabetes treated with insulin.
Development timeline for Symlin
| Date | Article |
|---|---|
| Oct 1, 2007 | Approval FDA Approves Symlin Pen-Injector Devices Offering Convenience andAccuracy for Symlin Use |
| Mar 16, 2005 | Approval Symlin Amylin Pharmaceuticals, Inc. - Treatment for Diabetes in conjunction with insulin |
| Sep 30, 2004 | Amylin Pharmaceuticals Submits Complete Response to FDA for Symlin |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.